Ginkgo Bioworks

Company

Investment-firm

Last deal

Amount

Grant

Stage

10.04.2024

Date

16

all rounds

$791.4M

Total amount

General

About Company
Ginkgo Bioworks is a biotechnology firm that designs, engineers, develops, tests, and licenses organisms.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Primus

founded date

01.01.2008

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

The company's platform enables biotechnology applications across diverse markets, including food and agriculture, industrial chemicals, and pharmaceuticals. Ginkgo Bioworks helps partners grow key ingredients for vaccines, plant-based meat, and materials for circular fashion while striving for diversity, equity, and inclusion in its culture and workforce.
Contacts